You just read:

CE Mark Granted to Nucleix's Bladder EpiCheck - Announcing Superior Results Over All Other Non-Invasive Tests in a European Multi-Center Study for Bladder Cancer Monitoring

News provided by

Nucleix

22 Mar, 2017, 08:00 ET